KR101343944B1 - Method for increasing funtional polysaccharides of barlry - Google Patents
Method for increasing funtional polysaccharides of barlry Download PDFInfo
- Publication number
- KR101343944B1 KR101343944B1 KR1020110145876A KR20110145876A KR101343944B1 KR 101343944 B1 KR101343944 B1 KR 101343944B1 KR 1020110145876 A KR1020110145876 A KR 1020110145876A KR 20110145876 A KR20110145876 A KR 20110145876A KR 101343944 B1 KR101343944 B1 KR 101343944B1
- Authority
- KR
- South Korea
- Prior art keywords
- barley
- glucan
- yeast
- fermented
- content
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 150000004676 glycans Chemical class 0.000 title abstract description 14
- 229920001282 polysaccharide Polymers 0.000 title abstract description 14
- 239000005017 polysaccharide Substances 0.000 title abstract description 14
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 75
- 238000000855 fermentation Methods 0.000 claims abstract description 12
- 230000004151 fermentation Effects 0.000 claims abstract description 12
- 241000209219 Hordeum Species 0.000 claims abstract 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 46
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 29
- 229910052799 carbon Inorganic materials 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 29
- 229910052757 nitrogen Inorganic materials 0.000 claims description 23
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 16
- 239000008103 glucose Substances 0.000 claims description 16
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 14
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 14
- 229960002442 glucosamine Drugs 0.000 claims description 14
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical group OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 9
- 229940041514 candida albicans extract Drugs 0.000 claims description 9
- 239000012138 yeast extract Substances 0.000 claims description 9
- 241001480003 Chaetothyriales Species 0.000 claims description 7
- 241000223678 Aureobasidium pullulans Species 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000001125 extrusion Methods 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 238000007796 conventional method Methods 0.000 abstract description 5
- 240000005979 Hordeum vulgare Species 0.000 description 64
- 229920002498 Beta-glucan Polymers 0.000 description 57
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000002609 medium Substances 0.000 description 17
- 229920001503 Glucan Polymers 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000010998 test method Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229940069780 barley extract Drugs 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229920002558 Curdlan Polymers 0.000 description 5
- 239000001879 Curdlan Substances 0.000 description 5
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 229940078035 curdlan Drugs 0.000 description 5
- 235000019316 curdlan Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 102100022624 Glucoamylase Human genes 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 235000002789 Panax ginseng Nutrition 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229920000310 Alpha glucan Polymers 0.000 description 3
- 235000007319 Avena orientalis Nutrition 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 3
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000013365 molecular weight analysis method Methods 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000019449 other food additives Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000007218 ym medium Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 보리에 함유된 기능성 다당류를 증가시키는 방법에 관한 것이다. 본 발명에 의한 제조방법은 보리를 전처리하고, 발효의 최적 조건을 찾아내어, 종래의 방법보다 다량의 다당류를 함유하는 배양액을 얻을 수 있다. The present invention relates to a method of increasing the functional polysaccharides contained in barley. The production method according to the present invention can pretreat barley, find the optimum conditions for fermentation, and obtain a culture solution containing a greater amount of polysaccharides than the conventional method.
Description
본 발명은 보리에 함유된 기능성 다당류를 증가시키는 방법에 관한 것이다. The present invention relates to a method of increasing the functional polysaccharides contained in barley.
보리는 수용성 식이섬유를 다량 함유하고 있는 국내 대표적인 기능성 농림자원이다. 보리는 콜레스테롤 저하 및 심혈관계 질환 조절 등에 효과가 있다고 알려진 β-글루칸, 에르고스테롤을 포함한 생리활성물질을 함유하고 있고 다이어트에 좋은 식이섬유를 다량 함유하고 있다. Barley is Korea's representative functional agricultural and forestry resource containing a large amount of water-soluble dietary fiber. Barley contains physiologically active substances including β-glucan and ergosterol, which are known to be effective in lowering cholesterol and controlling cardiovascular diseases, and contain a large amount of dietary fiber that is good for diet.
β-글루칸은 글로코오즈가 β-1,3 화학 결합을 중심으로 중합된 β-글루칸을 총칭하며, 버섯, 효모 등 미생물의 세포벽의 구성성분으로 존재 하거나 세포 외로 분비되는 미생물 유래의 β-글루칸과 보리, 귀리와 같은 맥아류의 식이 섬유에서 추출되는 식물성 β-글루칸이 있다. β-glucan is a generic term for β-glucan, in which glycosides are polymerized around β-1,3 chemical bonds. Vegetable β-glucan is extracted from dietary fiber of malts such as barley and oats.
보리, 귀리, 옥수수, 밀 등 곡류의 배유 및 호분층의 세포벽에 존재하는 β-글루칸은 β-글루코실 유닛이 β-(1,3)결합과 β-(1,4)결합으로 연결되어 가지가 없이 선형사슬로 구성된 단순β-glucan로서, 일반적으로 보리에는 약 2~8%의 β-글루칸이 함유되어있으며 보리의 세포벽은 주로 β-글루칸을 주성분으로 하고 있다. 이러한 β-glucan은 수용성 식이 섬유의 형태로 낮은 농도에서 높은 점성을 나타내며, 항암, 항콜레스테롤, 항산화, 면역증강 및 피부재생 효과 등과 같은 여러 가지 생리활성 촉진효과가 밝혀지고 있어 건강식품소재 및 식품첨가물로 이용이 증가되고 있다. Β-glucans present in the cell walls of cereal oils and barley of wheat, oats, corn, and wheat are connected by β- (1,3) and β- (1,4) bonds. It is a simple β-glucan composed of linear chains. Barley generally contains about 2 to 8% of β-glucan, and the cell wall of barley is mainly composed of β-glucan. The β-glucan has high viscosity at low concentrations in the form of water-soluble dietary fiber and has been found to promote various physiological activities such as anti-cancer, anti-cholesterol, antioxidant, immune-enhancing and skin regeneration effects. The use is increasing.
동물의 면역계에 대한 활성 증진력을 갖는 β-(1,3)-글루칸은 여러 가지 종류의 식용버섯, 효모, 보리, 귀리 등에 함유되어 있는 것으로 알려져 있다. 그러나 일반적으로 담자균의 자실체나 균사체에 함유되어 있는 β-글루칸은 생육, 재배 조건에 따라 함량이나 분자량 등이 크게 차이가 있고, 불순물을 포함하고 있어 분리 및 정제에 어려움이 따르며, 물에 대한 용해성이 낮아 다양한 용도로의 이용에 많은 제한이 있다.It is known that β- (1,3) -glucan, which has an ability to enhance the immune system of animals, is contained in various kinds of edible mushrooms, yeast, barley, oats, and the like. However, β-glucan generally contained in the fruiting body or mycelium of basidiomycetes varies greatly in content or molecular weight depending on growth and cultivation conditions, and it contains impurities, which makes it difficult to separate and purify. Solubility in water As a result, there are many restrictions on its use for various purposes.
이에 본 발명자들은 보리를 효과적으로 효모 배양하여 β-글루칸 또는 글루코사민 함량을 증진시키기 위하여 예의 노력한 결과, 열처리 또는 압출성형한 보리를 사용하여 특정 배지에서 배양한 결과, 기능성 다당류의 함량이 증가하는 것을 확인하고 본 발명을 완성하게 되었다.Therefore, the present inventors have made efforts to enhance the β-glucan or glucosamine content by effectively yeast culture of barley, and as a result of culturing in a specific medium using heat-treated or extruded barley, it was confirmed that the content of functional polysaccharides increased The present invention has been completed.
본 발명의 목적은 보리에 함유된 기능성 다당류를 증가시키는 방법 및 그 방법에 의하여 제조된 발효 보리를 제공하는 것이다. It is an object of the present invention to provide a method of increasing the functional polysaccharides contained in barley and fermented barley produced by the method.
상기 목적을 달성하기 위하여, 본 발명은 보리에 함유된 기능성 다당류를 증가시키는 방법으로서, 보리를 전처리하는 단계; 및 전처리된 보리에 효모를 가하여 발효시키는 단계를 포함하는, 기능성 다당류가 증가된 보리의 제조방법을 제공한다.In order to achieve the above object, the present invention provides a method for increasing the functional polysaccharide contained in barley, comprising the steps of pre-treating barley; And fermentation by adding yeast to the pretreated barley.
본 발명은 또한 상기 방법으로 제조된 발효 보리를 제공한다. The present invention also provides fermented barley prepared by the above method.
본 발명에 의한 제조방법은 보리를 전처리하고, 발효의 최적 조건을 찾아내어, 종래의 방법보다 다량의 다당류를 함유하는 배양액을 얻을 수 있다. The production method according to the present invention can pretreat barley, find the optimum conditions for fermentation, and obtain a culture solution containing a greater amount of polysaccharides than the conventional method.
도 1은 탄소원 종류에 따른, 효모 배양액에서의 β-글루칸의 함량을 비교한 것이다.
도 2는 질소원 종류에 따른, 효모 배양액에서의 β-글루칸의 함량을 비교한 것이다.
도 3은 탄소원 및 질소원에 따른 β-글루칸 생성에 대한 주효과도를 나타낸 것이다.
도 4는 탄소원과 질소원의 농도에 따른 β-글루칸 생성량에 대한 최적화를 나타낸 것이다.
도 5는 β-(1,3)-글루칸 구조의 표준물질인 커드란의 FT-IR 스펙트럼이다.
도 6은 흑효모 배양액에서의 FT-IR 스펙트럼이다.
도 7은 β-(1,3)-글루칸 구조의 표준물질인 커드란의 1H-NMR 스펙트럼이다.
도 8은 흑효모 배양액에서의 1H-NMR 스펙트럼이다.
도 9는 덱스트란 분자량 표준폼의 GPC 시스템을 이용한 분자량 std curve이다.
도 10은 GPC 시스템을 이용하여 효모 배양액의 분자량을 분석한 결과이다.1 compares the content of β-glucan in yeast culture according to the type of carbon source.
Figure 2 compares the content of β-glucan in the yeast culture according to the type of nitrogen source.
Figure 3 shows the main effect on the production of β-glucan according to the carbon source and nitrogen source.
Figure 4 shows the optimization for the β-glucan production amount according to the concentration of the carbon source and nitrogen source.
5 is an FT-IR spectrum of curdlan, a standard of β- (1,3) -glucan structure.
6 is an FT-IR spectrum in black yeast culture.
7 is a 1H-NMR spectrum of curdlan, a standard of β- (1,3) -glucan structure.
8 is a 1 H-NMR spectrum in a black yeast culture.
9 is a molecular weight std curve using the GPC system of dextran molecular weight standard form.
10 is a result of analyzing the molecular weight of the yeast culture using the GPC system.
본 발명의 일 관점은 보리에 함유된 기능성 다당류를 증가시키는 방법으로서, 보리를 전처리하는 단계; 및 전처리된 보리에 효모를 가하여 발효시키는 단계를 포함하는, 기능성 다당류가 증가된 보리의 제조방법에 관한 것이다.One aspect of the invention is a method of increasing the functional polysaccharides contained in barley, comprising the steps of: pre-treating barley; And fermentation by adding yeast to pretreated barley.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 전처리는 보리를 180℃ 내지 250℃의 온도에서 열처리한 것을 포함한다. 180℃ 미만의 온도에서 처리할 경우, 기능성 다당류 함량의 증가가 미미하였고, 250℃를 초과하는 온도에서 처리하는 경우, 보리가 탄화되었다. 상기와 같은 관점에서, 본 발명의 열처리는 185℃ 내지 240℃, 190℃ 내지 230℃, 195℃ 내지 220℃ 또는 200℃ 내지 210℃에서 수행될 수 있다.In the method of producing barley which is one aspect of the present invention, the pretreatment includes heat treatment of barley at a temperature of 180 ° C to 250 ° C. When treated at temperatures below 180 ° C., the increase in functional polysaccharide content was minimal, and when treated at temperatures above 250 ° C., barley carbonized. In view of the above, the heat treatment of the present invention may be carried out at 185 ℃ to 240 ℃, 190 ℃ to 230 ℃, 195 ℃ to 220 ℃ or 200 ℃ to 210 ℃.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 전처리는 보리를 압출 후 건조시키는 것을 포함한다. 본 명세서에서 "압출"은 강한 압력으로 눌러서 편평하게 만드는 것을 의미한다. 본 명세서에서 "건조"는 수분을 제거하여 수분이 없는 상태로 만드는 것으로, 건조기, 건조제를 사용하거나, 자연풍 또는 건조한 공기를 이용하여 물질 속의 수분을 증발시키는 것을 의미하며, 또는 물질을 넣은 용기를 저압으로 만들어 증발시키는 것을 포함할 수 있으나, 이에 제한되는 것은 아니다.In the method of producing barley which is one aspect of the present invention, the pretreatment includes drying the barley after extrusion. By "extrusion" is meant herein to press down with a strong pressure to make it flat. As used herein, the term "drying" refers to evaporating moisture in a material by using a dryer, a desiccant, or using natural air or dry air, to remove moisture, or to lower a container containing the material. It may include but not limited to evaporation.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 효모는 흑효모 (Aureobasidium pullulans)일 수 있다.In the method of producing barley, which is an aspect of the present invention, the yeast may be black yeast (Aureobasidium pullulans).
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 발효는 탄소원과 질소원을 포함하는 배지에서 발효시킬 수 있다.In the method of producing barley which is an aspect of the present invention, the fermentation may be fermented in a medium containing a carbon source and a nitrogen source.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 탄소원은 글루코오즈 또는 말토오즈일 수 있고, 구체적으로 글루코오즈일 수 있다.In the method of producing barley, which is an aspect of the present invention, the carbon source may be glucose or maltose, and specifically, may be glucose.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 배지는 15g/L 이상의 탄소원을 포함할 수 있다. 상기 배지는 15.5g/L 이상, 16g/L 이상, 16.5g/L 이상, 17g/L 이상, 17.5g/L 이상, 18g/L 이상, 18.5g/L 이상, 19g/L 이상, 19.5g/L 이상, 20 g/L 이상, 20.5g/L 이상, 21g/L 이상, 21.5g/L 이상, 22g/L 이상, 22.5g/L 이상, 23g/L 이상, 23.5g/L 이상, 24g/L 이상, 24.5g/L 이상 또는 25g/L 이상의 탄소원을 포함할 수 있다. 아울러, 상기 배지는 15 내지 200g/L의 탄소원을 포함할 수 있다. 배지의 탄소원이 15g/L미만인 경우, 발효가 이루어질 수 없고, 200g/L을 초과하는 경우, 배지에서 탄소원의 함량이 지나치게 높아져 다른 성분들을 정량으로 포함할 수 없는 것으로 확인되었다. 상기와 같은 관점에 있어서, 본 발명의 배지는 20 내지 180g/L, 25 내지 160g/L, 30 내지 140g/L, 35 내지 120g/L, 40 내지 100g/L 또는 45 내지 80g/L의 탄소원을 포함할 수 있다.In the method of producing barley, which is an aspect of the present invention, the medium may include a carbon source of 15 g / L or more. The medium is 15.5 g / L or more, 16 g / L or more, 16.5 g / L or more, 17 g / L or more, 17.5 g / L or more, 18 g / L or more, 18.5 g / L or more, 19 g / L or more, 19.5 g / L L or more, 20 g / L or more, 20.5 g / L or more, 21 g / L or more, 21.5 g / L or more, 22 g / L or more, 22.5 g / L or more, 23 g / L or more, 23.5 g / L or more, 24 g / Or at least 24.5 g / L or at least 25 g / L carbon source. In addition, the medium may contain a carbon source of 15 to 200g / L. If the carbon source of the medium is less than 15g / L, fermentation can not be made, if it exceeds 200g / L, it was confirmed that the content of the carbon source in the medium is too high to include other components in a quantitative manner. In view of the above, the medium of the present invention is a carbon source of 20 to 180g / L, 25 to 160g / L, 30 to 140g / L, 35 to 120g / L, 40 to 100g / L or 45 to 80g / L It may include.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 질소원은 질산 암모늄 (ammonium nitrate) 또는 효모 추출액 (yeast extract)일 수 있고, 구체적으로 효모 추출액일 수 있다.In the method of producing barley, which is an aspect of the present invention, the nitrogen source may be ammonium nitrate or yeast extract, and specifically, may be a yeast extract.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 배지는 1.5g/L 이하의 질소원을 포함할 수 있다. 상기 배지는 1.5g/L 이하, 1.45g/L 이하, 1.4g/L 이하, 1.35g/L 이하, 1.3g/L 이하, 1.25g/L 이하, 1.2g/L 이하, 1.15g/L 이하, 1.1g/L 이하, 1.05g/L 이하 또는 1g/L 이하의 질소원을 포함할 수 있다. 상기 배지는 0.1 내지 1.5g/L의 탄소원을 포함할 수 있다. 배지의 질소원이 0.1g/L미만인 경우, 배지에서 탄소원의 함량이 지나치게 높아져 다른 성분들을 정량으로 포함할 수 없고, 1.5g/L을 초과하는 경우, 발효가 이루어질 수 없는 것으로 확인되었다. 상기와 같은 관점에 있어서, 본 발명의 배지는 0.3 내지 1.3g/L, 0.5 내지 1.1g/L 또는 0.7 내지 0.9g/L의 질소원을 포함할 수 있다.In the method of producing barley, which is an aspect of the present invention, the medium may include a nitrogen source of 1.5 g / L or less. The medium is 1.5 g / L or less, 1.45 g / L or less, 1.4 g / L or less, 1.35 g / L or less, 1.3 g / L or less, 1.25 g / L or less, 1.2 g / L or less, 1.15 g / L or less , Up to 1.1 g / L, up to 1.05 g / L or up to 1 g / L of nitrogen. The medium may comprise a carbon source of 0.1 to 1.5g / L. When the nitrogen source of the medium is less than 0.1g / L, the content of the carbon source in the medium is too high to include other components in a quantitative, it was confirmed that the fermentation can not be made when it exceeds 1.5g / L. In view of the above, the medium of the present invention may comprise a nitrogen source of 0.3 to 1.3 g / L, 0.5 to 1.1 g / L or 0.7 to 0.9 g / L.
본 발명의 일 관점인 보리의 제조방법에 있어서, 상기 기능성 다당류는 β-글루칸 및 글루코사민으로 이루어진 군에서 선택되는 하나 이상의 다당류일 수 있고, 구체적으로 β-글루칸 및 글루코사민일 수 있다.In the method of preparing barley, which is an aspect of the present invention, the functional polysaccharide may be one or more polysaccharides selected from the group consisting of β-glucan and glucosamine, and specifically β-glucan and glucosamine.
본 발명은 다른 관점에서 상기 방법으로 제조된 발효 보리에 관한 것이다. The present invention relates to fermented barley produced by the above method in another aspect.
본 발명의 일 관점인 발효 보리에 있어서, 상기 발효 보리는 전체 중량에 대하여, β-글루칸이 3.5%이상 포함되고, 글루코사민이 3.85%이상 포함될 수 있다.In the fermented barley, which is an aspect of the present invention, the fermented barley may include 3.5% or more of β-glucan and 3.85% or more of glucosamine, based on the total weight.
본 발명의 일 관점인 발효 보리에 있어서, 상기 β-글루칸의 용해도는 50%이상일 수 있다.In fermented barley which is one aspect of the present invention, the solubility of β-glucan may be 50% or more.
본 발명의 일 관점인 발효 보리에 있어서, 상기 β-글루칸은 β-(1,3)/(1,6)-글루칸을 포함할 수 있다. 상기 β-(1,3)/(1,6)-글루칸은 발효 보리를 포함하는 발효액 전체 중량에 대하여, 0.27%이상 함유될 수 있다.In fermented barley, which is an aspect of the present invention, the β-glucan may include β- (1,3) / (1,6) -glucan. The β- (1,3) / (1,6) -glucan may be contained 0.27% or more based on the total weight of the fermentation broth including fermented barley.
본 발명은 또 다른 관점에서 발효 보리를 포함하는 식품 조성물에 관한 것이다. 본 발명은 또한 발효 보리를 포함하는 건강식품용 조성물에 관한 것이다. 일실시예에서, 본 발명에 따른 조성물을 포함하는 식품 첨가제, 기능성 식품 또는 건강식품 등을 제공한다. The present invention relates to a food composition comprising fermented barley in another aspect. The present invention also relates to a composition for health food comprising fermented barley. In one embodiment, a food additive, a functional food or a health food containing the composition according to the present invention is provided.
본 발명에 따른 식품 조성물은 발효 보리를 포함하는 다양한 형태의 식품 첨가제 또는 기능성 식품을 제공한다. 상기 조성물을 포함하는 침출차, 액상차, 음료, 발효유, 치즈, 요구르트, 주스, 생균제제 및 건강보조식품 등으로 가공될 수 있으며, 그 외 다양한 식품 첨가제의 형태로 사용될 수 있다. The food composition according to the present invention provides various types of food additives or functional foods including fermented barley. The composition may be processed into an extruded tea, a liquid tea, a beverage, a fermented milk, a cheese, a yogurt, a juice, a probiotic agent, a health supplement, and the like, and various other food additives.
일실시예에서 상기 조성물은, 본 발명이 목적으로 하는 주 효과를 손상시키지 않는 범위 내에서 주 효과에 상승 효과를 줄 수 있는 다른 성분 등을 함유할 수 있다. 예를 들어, 물성 개선을 위하여 향료, 색소, 살균제, 산화방지제, 방부제, 보습제, 점증제, 무기염류, 유화제 및 합성 고분자 물질 등의 첨가제를 더 포함할 수 있다. 그 외에도, 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자 다당 및 해초 엑기스 등의 보조 성분을 더 포함할 수도 있다. 상기 성분들은 제형 또는 사용 목적에 따라서 당업자가 어려움 없이 적의 선정하여 배합할 수 있으며, 그 첨가량은 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 선택될 수 있다. 예를 들어, 상기 성분들의 첨가량은, 조성물 전체 중량을 기준으로, 0.01~5 중량%, 보다 구체적으로는 0.01~3 중량% 범위일 수 있다.In one embodiment, the composition may contain other ingredients and the like that can give a synergistic effect to the main effect within a range that does not impair the main effect of the present invention. For example, additives such as perfume, coloring agent, bactericide, antioxidant, preservative, moisturizing agent, thickening agent, inorganic salt, emulsifier and synthetic polymer substance may be further added for improvement of physical properties. In addition, supplementary ingredients such as water soluble vitamins, oil soluble vitamins, polymer peptides, polymer polysaccharides and seaweed extract may be further included. The above components may be mixed and selected without difficulty by those skilled in the art depending on the purpose of formulation or use, and the amount thereof may be selected within a range that does not impair the objects and effects of the present invention. For example, the addition amount of the above components may be in the range of 0.01 to 5% by weight, more specifically 0.01 to 3% by weight, based on the total weight of the composition.
본 발명에 따른 조성물의 제형은 용액, 유화물, 점성형 혼합물, 타블렛, 분말 등의 다양한 형태일 수 있으며, 이는 단순 음용, 주사 투여, 스프레이 방식 또는 스퀴즈 방식 등의 다양한 방법으로 투여될 수 있다.The composition according to the present invention may be in various forms such as a solution, an emulsion, a viscous mixture, a tablet, a powder, etc., and may be administered by various methods such as simple drinking, injection administration, spraying or squeezing.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for illustrating the present invention and that the scope of the present invention is not construed as being limited by these embodiments.
보리 전처리(Barley pretreatment ( 알파화Alpha ) 및 액화/) And liquefaction / 당화공정Saccharification Process
자수정찰보리(영광농협, Hordeum vulgare L.)를 전열볶음기를 사용하여 100rpm이상으로 회전시키면서 200℃에서 10분 이상 볶음처리 하고 (알파화), 알파화된 보리를 회전식 밀러를 이용하여 분쇄하였다.Embroidery Scouting Barley The vulgare L.) was roasted at 200 ° C. for 10 minutes while rotating at 100 rpm or more using an electric roaster (alpha), and the alphalated barley was ground using a rotary mill.
상기 알파보리 600g에 이의 4배에 해당하는 물을 첨가한 후 α-아밀라아제(NOVOzyme), 글루코-아밀라아제(NOVOzyme) 각각을 1%, 0.5%씩 첨가한 후 60℃, 10시간 동안 반응시켜 액화, 당화시켰다.After adding the water corresponding to four times the
보리 전처리(Barley pretreatment ( 익스트루전Extrude ) 및 액화/) And liquefaction / 당화Glycation 공정 fair
보리를 동방향 완전 맞물림형 이축 압축 성형기(co-rotating intermeshing type twin-screw extruder, Hankook E.M Ltd., Gyeonggi-do, Korea)를 이용하여 압출시킨 후 (익스트루전), 상온에서 24시간 이상 건조하여 10%이하의 수분함량을 가지도록 건조하여, 회전식 밀러를 이용하여 분쇄하였다.Barley was extruded using a co-rotating intermeshing type twin-screw extruder (Hankook EM Ltd., Gyeonggi-do, Korea) and then dried at room temperature for at least 24 hours. Dried to a moisture content of 10% or less, and ground using a rotary mirror.
상기 익스트루전 보리 600g에 이의 4배에 해당하는 물을 첨가한 후 α-아밀라아제(NOVOzyme), 글루코-아밀라아제(NOVOzyme) 각각을 1%, 0.5%씩 첨가한 후 60℃, 10시간 동안 반응시켜 액화, 당화시켰다.After adding the water corresponding to four times of the extruded
3-1. 총 β-3-1. Β-total 글루칸Glucan 분석 analysis
본 시험법은 건강기능식품공전 Ⅲ.3.4.3 베타글루칸 시험법을 기본으로 하였으며, 시험과정은 다음과 같다.This test method is based on Ⅲ.3.4.3 Beta Glucan Test Method of Health Functional Food Code, and the test procedure is as follows.
① 상기 실시예 1 또는 2에 의하여 얻어진 보리, 및 무처리 보리를 각각 2ml 취한 뒤, 10 ml의 증류수를 가한다.(1) Take 2 ml of the barley obtained from Example 1 or 2 and untreated barley, respectively, and then add 10 ml of distilled water.
② 아밀라아제 200 ㎕와 글루코아밀라아제 100㎕ 를 넣고 60 ℃에서 2시간 동안 진탕하여 효소분해 시킨다.② Add 200 μl of amylase and 100 μl of glucoamylase and shake the enzyme at 60 ° C. for 2 hours.
③ 2시간 후, 80 ㎕ 프로테아제를 넣고 2시간 동안 진탕하여 효소분해시킨다.③ After 2 hours, add 80 μl protease and shake for 2 hours to enzymatically decompose.
④ 효소분해물에 95% 에탄올 40 ml을 가하여 4℃에서 12시간 동안 침전시킨다.④ Add 40 ml of 95% ethanol to the enzyme degradation product and precipitate at 4 ℃ for 12 hours.
⑤ 위의 용액을 원심분리 (6000rpm, 20분) 하여 시료의 침전물을 취한다.⑤ Centrifuge the above solution (6000 rpm, 20 minutes) to take the sediment of the sample.
⑥ 침전물에 10ml의 증류수를 가하여 균질화시킨다.⑥ Homogenize the precipitate by adding 10 ml of distilled water.
⑦ 위의 용액을 5배 희석한 후, 5%의 페놀용액 1 ml과 황산 5 ml을 가하여 혼합 한 후, 실온에서 20분간 반응시킨 후 파장 470 nm에서 흡광도를 측정한다.⑦ Dilute the
⑧ β-glucan 함량 계산법은 아래와 같다.⑧ β-glucan content calculation method is as follows.
β-glucan 함량 (mg/ml) = C * a/S *10 *1/1000 * 0.9β-glucan content (mg / ml) = C * a / S * 10 * 1/1000 * 0.9
C : 시험용액중의 glucose 농도 (㎍/ml)C: glucose concentration in test solution (㎍ / ml)
a : 시험용액의 전량 (ml)a: total amount of test solution (ml)
10 : 희석배수10: Dilution factor
S : 시료 채취량 (ml)S: Amount of sample (ml)
1/1000 : 단위 환산 계수1/1000: Unit conversion factor
0.9 : 베타글루칸 전환계수 (162/180)0.9: beta glucan conversion factor (162/180)
3-2. 수용성 베타-3-2. Water Soluble Beta- 글루칸Glucan 및 불용성 베타- And insoluble beta- 글루칸의Glucan 함량 측정 Content measurement
상기 실시예 1 또는 2에 의하여 얻어진 보리, 및 무처리 보리에 대하여 각 0.5g을 튜브에 넣고 30ml 증류수로 38℃의 진탕항온기(75rpm)에서 2시간 추출하였다. 추출 후 튜브는 3000rpm에서 5분간 원심분리하였으며, 상층액을 제거하였다. 침전물은 다시 증류수로 세척하고 원심분리(3000rpm, 5분)를 2회 시행하여, 불용성 베타-글루칸 측정을 위한 시료로 사용하였다. 상기 시료를 이용하여 실시예 3-1의 방법에 따라, 불용성 베타-글루칸의 함량을 측정하였다.0.5 g of each of the barley obtained from Example 1 or 2 and untreated barley was put into a tube and extracted with 30 ml of distilled water at 38 ° C. in a shaking thermostat (75 rpm) for 2 hours. After extraction, the tube was centrifuged at 3000 rpm for 5 minutes and the supernatant was removed. The precipitate was washed again with distilled water and centrifuged twice (3000 rpm, 5 minutes), and used as a sample for measuring insoluble beta-glucan. According to the method of Example 3-1 using the sample, the content of insoluble beta-glucan was measured.
수용성 베타-글루칸의 함량은 총 베타-글루칸 함량에서 불용성 베타-글루칸 함량을 뺀 수치로 계산하였다. The water-soluble beta-glucan content was calculated by subtracting the insoluble beta-glucan content from the total beta-glucan content.
3-3. 용해도 측정3-3. Solubility measurement
실시예 3-1에 의하여 얻어진 총 베타-글루칸 함량 및 실시예 3-2에 의하여 얻어진 수용성 베타-글루칸의 함량으로, 다음 식을 이용하여 베타-글루칸의 용해도를 계산하였다. As the total beta-glucan content obtained in Example 3-1 and the water-soluble beta-glucan content obtained in Example 3-2, the solubility of beta-glucan was calculated using the following formula.
베타-글루칸 용해도 = 수용성 베타-글루칸 함량/총 베타-글루칸 함량 × 100Beta-Glucan Solubility = Water Soluble Beta-Glucan Content / Total Beta-Glucan Content × 100
3-4. 글루코사민 함량 측정3-4. Glucosamine Content Determination
상기 실시예 1 또는 2에 의하여 얻어진 보리, 및 무처리 보리 각각을 건조하여 속실렛 추출기를 이용하여 헥산으로 탈지과정을 거친 후, 탈지한 시료를 풍건하고 10배의 물을 가하여 추출한 후, 이를 유리 필터로 여과하였다. 이 여과액 10ml에 HCL 7ml과 H2O 3ml을 혼합한 후, 이 액 중 5mL을 취하여 탈기 밀봉한 후 110℃에서 24시간 반응으로 키토 올리고당을 글루코사민으로 분해하였다. 분해된 시료는 60℃의 온도에서 감압 농축하여 HCl과 H2O를 제거한 후 일정량의 물에 용해한 후 HPLC분석시료로 사용하였다. 컬럼은 Bondclone 10 NH2를 사용하였으며, 유속은 1ml/min, 온도는 35℃에서 분석하였다.After drying the barley obtained by Example 1 or 2, and each of the untreated barley and degreasing with hexane using a Soxhlet extractor, the degreased sample was air-dried and extracted by adding 10 times water, which was then liberated. Filter by filter. After mixing 7 ml of HCL and 3 ml of H 2 O in 10 ml of the filtrate, 5 ml of the filtrate was taken out and sealed by degassing. The chito oligosaccharide was decomposed into glucosamine by reaction at 110 ° C. for 24 hours. The decomposed sample was concentrated under reduced pressure at a temperature of 60 ℃ to remove HCl and H 2 O, dissolved in a certain amount of water and used as an HPLC analysis sample.
상기 실시예 3에 의하여 얻어진 결과는 다음 표 1과 같다.The results obtained in Example 3 are shown in Table 1 below.
함량
(%,w/w)Total β-glucan
content
(%, w / w)
β-글루칸
함량 (%,w/w)Insoluble
β-glucan
Content (%, w / w)
β-글루칸 함량 (%,w/w)receptivity
β-glucan content (%, w / w)
(%)β-glucan solubility
(%)
함량
(%,w/w)Glucosamine
content
(%, w / w)
(실시예 2)Extruded barley
(Example 2)
효모 배양 최적화 조건 선정Selection of conditions for optimizing yeast culture
4-1. 4-1. 흑효모Black yeast ( ( AureobasidiumAureobasidium pullulanspullulans ( ( DEDE BARYBARY ) ) ARNARN .))의 배양 최적화를 위한 For optimizing culture of.)) 배지원Badge 및 배양 농도 선정 실험 And culture concentration selection experiment
최적의 탄소원을 선정하기 위한 탄소원 후보는 갈락토오즈, 말토오즈, 프럭토오즈, 락토오즈, 글루코오즈, 수크로오즈 및 자이로오즈를 사용하였다. 흑효모 (Aureobasidium pullulans)의 배지는 1g/L의 K2HPO4, 1g/L의 NaCl, 0.2g/L의 MgSO4, 2.5g/L의 yeast extract 및 0.6g/L의 (NH4)2SO4이 포함된 것을 사용하였으며, 상기 각각의 탄소원을 각 5g/L 넣어 비교한 결과, 표 2와 같은 결과를 얻었으며, 이를 그래프로 나타내었다 (도 1).The candidate carbon sources for selecting the optimal carbon source were galactose, maltose, fructose, lactose, glucose, sucrose and gyrose. Aureobasidium pullulans medium contains 1 g / L K 2 HPO 4 , 1 g / L NaCl, 0.2 g / L MgSO 4 , 2.5 g / L yeast extract and 0.6 g / L (NH 4 ) 2 SO 4 was used, and each carbon source was put into each 5g / L, and the results were obtained as shown in Table 2, which is shown as a graph (FIG. 1).
(mg/ml)β-glucan content
(mg / ml)
더불어, 최적의 질소원을 선정하기 위한 질소원 후보로 질산 암모늄 (ammonium nitrate), 효모 추출액 (yeast extract), 펩톤 (peptone), 황산 암모늄 (ammonium sulfate) 및 엿당 추출액 (malt extract)를 이용하였다. 흑효모 (Aureobasidium pullulans)의 배지는 탄소원으로 5g/L의 sucrose를 이용하였고, 무기원으로 1g/L의 K2HPO4, 1g/L의 NaCl, 0.2g/L의 MgSO4을 넣고 각각의 질소원을 넣어 비교한 결과, 표 3과 같은 결과를 얻었으며, 이를 그래프로 나타내었다 (도 2).In addition, ammonium nitrate, yeast extract, peptone, ammonium sulfate, and malt extract were used as nitrogen source candidates for selecting an optimal nitrogen source. The medium of black yeast ( Aureobasidium pullulans ) used 5g / L sucrose as a carbon source, 1g / L K 2 HPO 4 , 1g / L NaCl, 0.2g / L MgSO 4 as an inorganic source As a result of comparing the results, a result as shown in Table 3 was obtained, and this is shown as a graph (FIG. 2).
(mg/ml)β-glucan content
(mg / ml)
탄소원 및 질소원 선정 실험을 좀 더 구체화 시키기 위해서 7가지 탄소원 후보 비교 결과와 6가지의 질소원 후보 비교 결과 중 β-글루칸의 생산함량이 높았던 후보를 각 3종류 (탄소원 : 말토오즈, 글루코오즈, 수크로오즈; 질소원 : 질산 암모늄, 효모 추출액, 펩톤)씩 선별하여 일부실시법(완전요인실험법, 3수준, 미니탭)을 실시하여 탄소원, 질소원 각각에 대하여 최적의 배지 조합를 선정하였다 (도 3). To further refine the carbon source and nitrogen source selection experiments, three types of candidates with high β-glucan production among the seven carbon source candidates and six nitrogen source candidates were selected (carbon sources: maltose, glucose and sucrose). Oz: Nitrogen source: ammonium nitrate, yeast extract, peptone) was selected to perform some method (complete factor test method,
아울러 선정된 탄소원과 질소원 조합에서 각각의 배양 최적농도를 정하기 위한 반응 표면 분석법 (RSM)을 실시하기 위해 각각 (탄소원 : 말토오즈, 글루코오즈, 수크로오즈; 질소원 : 질산 암모늄, 효모 추출액, 펩톤)의 농도수준을 3수준으로 실험을 실시하였다. 실험에 사용된 탄소원의 농도(알파 값 고려)는 17.1g/L, 15g/L, 10g/L, 5g/L, 2.9g/L로 나누었고, 질소원의 농도는 8.5g/L, 7.5g/L, 5g/L, 2.5g/L, 1.5g/L로 실험하였으며, 무기원으로는 1g/L의 K2HPO4, 1g/L의 NaCl, 0.2g/L의 MgSO4을 넣어 배양하였다. 추후 생산된 β-글루칸의 함량을 비교하여 최적의 탄소원, 질소원 농도를 선정하였다 (도 4).In addition, to perform response surface analysis (RSM) to determine the optimal concentration of each culture in the selected carbon source and nitrogen source combination (carbon source: maltose, glucose, sucrose; nitrogen source: ammonium nitrate, yeast extract, peptone) The experiment was conducted at the concentration level of 3. The concentrations of carbon sources used in the experiment (with alpha values) were divided into 17.1 g / L, 15 g / L, 10 g / L, 5 g / L, and 2.9 g / L. The concentrations of nitrogen sources were 8.5 g / L and 7.5 g / L. , 5g / L, 2.5g / L, 1.5g / L were experimented, and as an inorganic source, 1g / L K 2 HPO 4 , 1g / L NaCl, 0.2g / L MgSO 4 was incubated. Subsequently, the optimum carbon source and nitrogen source concentrations were selected by comparing the content of β-glucan produced later (FIG. 4).
실시예 1 또는 실시예 2에 의하여 전처리한 보리를 이용하여 발효시키는 경우, 기능성 다당류의 함량 변화를 분석하기 위하여, 다음 (표 4)과 같은 실험군을 사용하였다.In the case of fermentation using barley pretreated by Example 1 or Example 2, in order to analyze the change in the content of functional polysaccharides, the experimental group as shown in Table 4 was used.
Barley 1 ) heat-treated according to Example 1 + glucose 17.1 g / L + ammonium nitrate 1.5 g / L + yeast
1) 최종 효모 배양 시 열처리한 보리는 배양액 부피 대비 20% 이상 첨가하였음.1) Barley heat-treated in the final yeast culture was added more than 20% of the culture volume.
5-1. 효모 발효조 배양5-1. Yeast Fermenter Culture
상기 표 4의 실험예 1을 얻기 위하여, 실시예 1에 의하여 열처리한 보리를 글루코오즈 (17.1g/L), 질산 암모늄 1.5g/L 조건 하에서, 흑효모 (Aureobasidium pullulans (DE BARY) ARN.))로 발효시켰다. 효모 PDA 플레이트에 보관한 균주를 YM 배지에 접종하여 30℃, 150rpm에서 48시간 동안 배양하였다. 발효조 실험은 발효 용량은 1L로 하여 배양액의 5%를 발효조에 접종하였으며 1, 13, 18, 24, 38, 43시간 후의 배양액을 샘플링하여 pH 변화, 균체량, β-glucan 함량, glucosamine 함량을 파악하였다.In order to obtain the Experimental Example 1 of Table 4, barley heat-treated according to Example 1 under the conditions of glucose (17.1 g / L), ammonium nitrate 1.5 g / L, black yeast ( Aureobasidium pullulans (DE BARY) ARN.)). Strains stored in yeast PDA plates were inoculated in YM medium and incubated at 30 ° C. and 150 rpm for 48 hours. In the fermenter experiment, the fermentation volume was 1L and 5% of the culture was inoculated into the fermenter, and after 1, 13, 18, 24, 38, and 43 hours, the culture was sampled to determine pH change, cell weight, β-glucan content, and glucosamine content. .
5-2. 총 β-5-2. Β-total 글루칸Glucan 함량 분석 Content analysis
본 시험법은 건강기능식품공전 Ⅲ.3.4.3 베타글루칸 시험법을 기본으로 하였으며, 시험과정은 다음과 같다.This test method is based on Ⅲ.3.4.3 Beta Glucan Test Method of Health Functional Food Code, and the test procedure is as follows.
① 상기 비교실험예 1내지3 및 실험예 1 각각의 시료 2ml을 취한 뒤 10 ml의 증류수를 가한다.① Take 2 ml of each sample of
② 아밀라아제 200 ㎕와 글루코아밀라아제 100㎕ 를 넣고 60 ℃에서 2시간 동안 진탕하여 효소분해 시킨다.② Add 200 μl of amylase and 100 μl of glucoamylase and shake the enzyme at 60 ° C. for 2 hours.
③ 2시간 후, 80 ㎕ 프로테아제를 넣고 2시간 동안 진탕하여 효소분해 시킨다.③ After 2 hours, add 80 μl protease and shake for 2 hours to perform enzymatic digestion.
④ 효소분해물에 95% 에탄올 40 ml을 가하여 4℃에서 12시간 동안 침전시킨다.④ Add 40 ml of 95% ethanol to the enzyme degradation product and precipitate at 4 ℃ for 12 hours.
⑤ 위의 용액을 원심분리 (6000rpm, 20분) 하여 시료의 침전물을 취한다.⑤ Centrifuge the above solution (6000 rpm, 20 minutes) to take the sediment of the sample.
⑥ 침전물에 10ml의 증류수를 가하여 균질화시킨다.⑥ Homogenize the precipitate by adding 10 ml of distilled water.
⑦ 위의 용액을 5배 희석한 후, 5%의 페놀용액 1 ml과 황산 5 ml을 가하여 혼합 한 후, 실온에서 20분간 반응시킨 후 파장 470 nm에서 흡광도를 측정한다.⑦ Dilute the
⑧ β-글루칸 함량 계산법은 아래와 같다.⑧ β-glucan content calculation method is as follows.
β-glucan 함량 (mg/ml) = C * a/S *10 *1/1000 * 0.9β-glucan content (mg / ml) = C * a / S * 10 * 1/1000 * 0.9
C : 시험용액중의 glucose 농도 (㎍/ml)C: glucose concentration in test solution (㎍ / ml)
a : 시험용액의 전량 (ml)a: total amount of test solution (ml)
10 : 희석배수10: Dilution factor
S : 시료 채취량 (ml)S: Amount of sample (ml)
1/1000 : 단위 환산 계수1/1000: Unit conversion factor
0.9 : 베타글루칸 전환계수 (162/180)0.9: beta glucan conversion factor (162/180)
5-3. β-(1,3)/(1,6)-5-3. β- (1,3) / (1,6)- 글루칸Glucan 함량 분석 Content analysis
β-(1,3)/(1,6)-글루칸의 함량은 Mushroom and yeast beta-glucan kit (Megazyme, Ireland)를 이용하여 분석하였다. 글루칸을 측정하기 위해, 상기 비교실험예 1내지3 및 실험예 1 각각의 시료에 HCl을 주입하여 30℃ 항온수조에서 반응시키며, 15분마다 vortex하여 총 45분 동안 충분히 녹인다. 여기에 증류수를 넣고 끓는 물에서 2시간 동안 반응 시킨 후 상온에서 식혀 2N KOH를 넣는다. 반응액을 일정량이 되도록 200mM 아세트산 나트륨 버퍼 (pH 5.0)를 용량에 맞추어 넣고 1,500g에서 10분 동안 원심분리하여 상등액을 얻었다. 상등액을 취하여 exo-1,3,-β-글루코시다아제 (20U/ml)과 β-글루코시다아제 (4U/ml)를 넣고 40℃에서 60분 동안 반응시킨 후, GOPOD 시약을 넣어 40℃에서 20분간 반응 후 510nm에서 흡광도를 측정하였다.The content of β- (1,3) / (1,6) -glucan was analyzed using Mushroom and yeast beta-glucan kit (Megazyme, Ireland). In order to measure the glucan, HCl was injected into each of the Comparative Experimental Examples 1 to 3 and Experimental Example 1, and reacted in a 30 ° C. constant temperature water bath. Add distilled water to it and let it react in boiling water for 2 hours, then cool it at room temperature and add 2N KOH. 200 mM sodium acetate buffer (pH 5.0) was added at a constant volume to a constant amount, and the supernatant was obtained by centrifugation at 1,500 g for 10 minutes. Take the supernatant, add exo-1,3, -β-glucosidase (20U / ml) and β-glucosidase (4U / ml), and react for 60 minutes at 40 ° C. Then, add GOPOD reagent at 40 ° C. After the reaction for 20 minutes, the absorbance at 510 nm was measured.
α-글루칸을 측정하기 위해서, 시료를 2N KOH를 넣고 얼음에 20분 동안 vortex 하면서 녹였다. 1.2M 아세트산 나트륨 버퍼 (pH 3.8) 를 넣고, 아미로글루코시다아제 전환효소 (amyloglucosidase invertase)를 넣어 40℃에서 30분 동안 반응 시킨다. 반응이 끝난 후, 1,500g에서 10분간 원심분리 하여 상등액을 얻는다. 상등액에 GOPOD시약을 넣어 40℃에서 20분간 반응 후 510nm에서 흡광도를 측정하였다. 총 글루칸과 α-글루칸을 측정하여 얻어진 흡광도 값을 표준물질인 글루코오즈를 이용하여 %(w/w)농도로 계산하여 총 글루칸의 값에서 α-글루칸의 값을 빼주어 β-(1,3)/(1,6)-글루칸 함량을 구하였다.To measure α-glucan, the sample was dissolved in 2N KOH and vortexed for 20 minutes on ice. 1.2M sodium acetate buffer (pH 3.8) was added thereto, followed by addition of amyloglucosidase invertase and reaction at 40 ° C for 30 minutes. After the reaction is completed, the supernatant is obtained by centrifugation at 1500 g for 10 minutes. The GOPOD reagent was added to the supernatant, and the absorbance was measured at 510 nm after 20 minutes of reaction at 40 ° C. The absorbance values obtained by measuring the total glucan and α-glucan were calculated by the concentration of% (w / w) using glucose, a standard substance, and the value of α-glucan was subtracted from the value of total glucan and β- (1,3 ) / (1,6) -glucan content was determined.
5-4.글루코사민 함량 분석5-4.Glucosamine Content Analysis
상기 비교실험예 1내지3 및 실험예 1 각각을 건조하여 속실렛 추출기를 이용하여 헥산으로 탈지과정을 거친 후, 탈지한 시료를 풍건하고 10배의 물을 가하여 추출한 후, 이를 유리 필터로 여과하였다. 이 여과액 10ml에 HCL 7ml과 H2O 3ml을 혼합한 후, 이 액 중 5mL을 취하여 탈기 밀봉한 후 110℃에서 24시간 반응으로 키토 올리고당을 글루코사민으로 분해하였다. 분해된 시료는 60℃의 온도에서 감압 농축하여 HCl과 H2O를 제거한 후 일정량의 물에 용해한 후 HPLC분석시료로 사용하였다. 컬럼은 Bondclone 10 NH2를 사용하였으며, 유속은 1ml/min, 온도는 35℃에서 분석하였다.Each of Comparative Examples 1 to 3 and Experimental Example 1 was dried, degreased with hexane using a Soxhlet extractor, and the degreased sample was air-dried and extracted by adding 10 times water, which was then filtered through a glass filter. . After mixing 7 ml of HCL and 3 ml of H 2 O in 10 ml of the filtrate, 5 ml of the filtrate was taken out and sealed by degassing. The chito oligosaccharide was decomposed into glucosamine by reaction at 110 ° C. for 24 hours. The decomposed sample was concentrated under reduced pressure at a temperature of 60 ℃ to remove HCl and H 2 O, dissolved in a certain amount of water and used as an HPLC analysis sample.
상기 실시예 5에 의하여 얻어진 결과는 다음 표 5과 같다.The results obtained in Example 5 are shown in Table 5 below.
함량
(mg/ml)β-glucan
content
(mg / ml)
함량
(mg/ml)β- (1,3) / (1,6) -glucan
content
(mg / ml)
함량
(mg/ml)Glucosamine
content
(mg / ml)
6-1. 6-1. FTFT -- IRIR 분석과 핵자기공명 ( Analysis and Nuclear Magnetic Resonance ( NMRNMR ) 분석) analysis
상기 표 4의 실험예 1에 의하여 생산되는 β-글루칸의 구조분석을 위하여 48시간동안 배양한 배양액에서 FT-IR와 NMR 분석을 시행하였다.For structural analysis of β-glucan produced by Experimental Example 1 of Table 4, FT-IR and NMR analysis were performed in a culture cultured for 48 hours.
배양액은 8000g에서 20분간 원심분리하고 균체를 제거한 상등액을 회수하여 2배 용량의 95% 에탄올을 첨가하고 잘 혼합하여 4℃에서 하룻밤 동안 방치하였다. 세척한 침전물을 적당한 양의 증류수에 용해시킨 다음, 2일 동안 5회 증류수를 바꾸어 주면서 투석하여 염성분을 포함한 저분자물질을 제거하였다. 투석막 (Dialysis membrane, Spectrum Lab, USA)은 배제 분자량이 14,000인 것은 사용하였으며, 상기 투석액의 내부 분획을 동결 건조하여 회수였다.The culture solution was centrifuged at 8000 g for 20 minutes, and the supernatant from which the cells were removed was recovered, added twice the volume of 95% ethanol, mixed well, and left overnight at 4 ° C. The washed precipitate was dissolved in an appropriate amount of distilled water, and then dialyzed while changing distilled water five times for two days to remove low molecular weight substances including salt components. Dialysis membrane (Dialysis membrane, Spectrum Lab, USA) was used as the exclusion molecular weight of 14,000, was recovered by freeze drying the internal fraction of the dialysate.
동결 건조된 시료를 KBr 중에 미량 넣어 잘 분쇄한 후 시료제조기로 박막을 만든 후 분석하는 KBr disc법으로 FT-IR 분석을 하였으며, FT-IR 분광기는 JASCO 4100 FT-IR 분광기를 이용하였다. 정확한 비교분석을 위해 기준물질으로 β-(1,3)-글루칸의 표준물질인 커드란(curdlan, sigma)의 데이터 (도 5)를 이용하여 분석한 결과, 도 6을 얻었다.After freeze-dried samples were pulverized in a small amount of KBr, FT-IR spectroscopy was performed by KBr disc method. For accurate comparison analysis, 6 was obtained using the data of curdlan (curdlan, sigma), a standard of β- (1,3) -glucan, as a reference material.
위와 같은 방법으로 동결건조된 시료를 커드란을 표준물질 (도 7)로 하여 1H-NMR 분석한 결과, 도 8을 얻었다. 500 ㎕의 D2O에 100mg의 시료를 녹인 후 25℃에서 Bruker Avance-FT-NMR 분광계 (400MHz)로 분석하였고, TMS(Tetramethylsilane)를 내부 표준물질로 사용하였다.1H-NMR analysis of the sample lyophilized in the same manner as above using curdlan as a reference material (FIG. 7) yielded FIG. 8. 100 mg of sample was dissolved in 500 μl of D 2 O, and analyzed by Bruker Avance-FT-NMR spectrometer (400 MHz) at 25 ° C., and TMS (Tetramethylsilane) was used as an internal standard.
6-2. 분자량 분석6-2. Molecular Weight Analysis
상기 표 4의 실험예 1에 의하여 생산되는 β-글루칸의 구조분석을 위하여 48시간 동안 배양한 배양액을 8000g에서 20분간 원심분리하고 균체를 제거한 상등액을 회수하여 2배 용량의 95% 에탄올을 첨가하고 잘 혼합하여 4℃에서 하룻밤 동안 방치하였다. 세척한 침전물을 적당한 양의 증류수에 용해시킨 다음, 2일 동안 5회 증류수를 바꾸어 주면서 투석하여 염성분을 포함한 저분자물질을 제거하였다. 투석막 (Dialysis membrane, Spectrum Lab, USA)은 배제 분자량이 14,000인 것은 사용하였다. For structural analysis of the β-glucan produced by Experimental Example 1 of Table 4, centrifuged at 8000 g for 20 minutes, and the supernatant from which the cells were removed was recovered, and a double volume of 95% ethanol was added thereto. Mix well and leave at 4 ° C. overnight. The washed precipitate was dissolved in an appropriate amount of distilled water, and then dialyzed while changing distilled water five times for two days to remove low molecular weight substances including salt components. Dialysis membrane (Dialysis membrane, Spectrum Lab, USA) was used as the exclusion molecular weight of 14,000.
상기에서 분리/정제한 β-글루칸의 분자량을 측정하기 위해 TSK PWXL6000(Viscotek, USA) 컬럼을 사용하여 GPC 크로마토그래피를 실시한 결과, 도 9를 얻었다. HPLC의 이동상은 HPLC용 Water를 사용하였으며, 유속은 1ml/min으로 설정하였다. Sigma dextran 분자량 표준물질을 사용하여 분자량 표준곡선을 그린 결과, 도 10을 얻었다. In order to measure the molecular weight of the β-glucan separated / purified above, GPC chromatography was performed using a TSK PWXL6000 (Viscotek, USA) column to obtain FIG. 9. HPLC mobile water was used for HPLC, and the flow rate was set to 1 ml / min. The molecular weight standard curve was drawn using the Sigma dextran molecular weight standard, and FIG. 10 was obtained.
본 발명에 의한 발효 보리를 유효성분으로 함유하는 조성물은 하기와 같이 여러 가지 제형으로 응용 가능하지만, 이에 한정되는 것은 아니다.The composition containing the fermented barley according to the present invention as an active ingredient is applicable to various formulations as follows, but is not limited thereto.
[제제예 1] 연질캅셀제[Formulation Example 1] Soft capsule
발효 보리 추출물 330 mg, 홍삼추출물 50 mg, 팜유 2 mg, 팜경화유 8 mg, 황납 4 mg 및 레시틴 6 mg을 혼합하고, 통상의 방법에 따라 1 캡슐당 400 mg씩 충진하여 연질캅셀을 제조하였다.Fermented barley extract 330 mg,
[제제예 2] 정제[Formulation Example 2] Tablets
발효 보리 추출물 150 mg, 포도당 100 mg, 홍삼추출물 50 mg, 전분 96 mg 및 마그네슘 스테아레이트 4 mg을 혼합하고 30% 에탄올을 40 mg 첨가하여 과립을 형성한 후, 60℃에서 건조하고 타정기를 이용하여 정제로 타정하였다.Fermented barley extract 150 mg, glucose 100 mg,
[제제예 3] 과립제[Formulation Example 3] Granules
발효 보리 추출물 150 mg, 포도당 100 mg, 홍삼추출물 50 mg 및 전분 600 mg을 혼합하고 30% 에탄올을 100 mg 첨가하여 과립을 형성한 후, 60℃에서 건조하여 과립을 형성한 다음 포에 충진하였다. 내용물의 최종 중량은 1 g으로 하였다.Fermented barley extract 150 mg, glucose 100 mg,
[제제예 4] 드링크제[Example 4] Drinks
발효 보리 추출물 150 mg, 포도당 10 g, 홍삼추출물 50 mg, 구연산 2 g 및 정제수 187.8 g을 혼합하고 병에 충진하였다. 내용물의 최종 용량은 200 ml로 하였다.Fermented barley extract 150 mg, glucose 10 g,
[제제예 5] 건강 식품의 제조[Formulation Example 5] Preparation of health food
발효 보리 추출물.................................... 1000 ㎎ Fermented Barley Extract .................................... 1000 mg
비타민 혼합물 Vitamin mixture
비타민 A 아세테이트.......................70 ㎍ Vitamin A Acetate ......... 70 μg
비타민 E ............................................ 1.0 ㎎ Vitamin E ............................................ 1.0 mg
비타민 B1........................................... 0.13 ㎎ Vitamin B1 ........................................... 0.13 mg
비타민 B2 .......................................... 0.15 ㎎ Vitamin B2 .......................................... 0.15 mg
비타민 B6........................................... 0.5 ㎎ Vitamin B6 ......................................... 0.5 mg
비타민 B12......................................... 0.2 ㎍ Vitamin B12 ......................... 0.2 μg
비타민 C............................................. 10 ㎎ Vitamin C ............................................. 10 mg
비오틴.................................................. 10 ㎍ Biotin ... 10 ㎍
니코틴산아미드.................................. 1.7 ㎎ Nicotinic acid amide .................................. 1.7 mg
엽산...................................................... 50 ㎍ Folic acid ................................................. ..... 50 μg
판토텐산 칼슘.................................... 0.5 ㎎ Calcium pantothenate .................................... 0.5 mg
무기질 혼합물 Mineral mixture
황산제1철.......................................... 1.75 ㎎ Ferrous Sulfate ......................................... 1.75 mg
산화아연.............................................. 0.82 ㎎ Zinc oxide ............................................ 0.82 mg
탄산마그네슘...................................... 25.3 ㎎ Magnesium carbonate ...................................... 25.3 mg
제1인산칼륨.......................................... 15 ㎎ Potassium Phosphate ......................................... 15 mg
제2인산칼슘.......................................... 55 ㎎ Secondary calcium phosphate ...................................... 55 mg
구연산칼륨............................................ 90 ㎎ Potassium citrate ............................................ 90 mg
탄산칼슘.............................................. 100 ㎎ Calcium carbonate .............................................. 100 mg
염화마그네슘..................................... 24.8 ㎎ Magnesium chloride ..................................... 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the above-mentioned vitamin and mineral mixture is comparatively mixed with a composition suitable for health food as a preferred embodiment, the compounding ratio may be arbitrarily modified, and the above ingredients are mixed according to a conventional method for producing healthy foods , Granules can be prepared and used in the manufacture of health food compositions according to conventional methods.
[제제예 6] 건강 음료의 제조 Preparation Example 6 Preparation of Healthy Drinks
발효 보리 추출물................................... 1000 ㎎ Fermented Barley Extract ......................................... 1000 mg
구연산..................................................... 1000 ㎎ Citric acid ................................................. ... 1000 mg
올리고당..................................................... 100 g oligosaccharide................................................. .... 100 g
매실농축액..................................................... 2 g Plum concentrate ................................................ ..... 2 g
타우린............................................................ 1 g Taurine ................................................. ........... 1 g
정제수를 가하여 전체......................... 900 ㎖ Purified water was added to the mixture to complete 900 ml
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2ℓ용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다.The above components were mixed according to a conventional health drink manufacturing method, and the mixture was heated at 85 DEG C for about 1 hour with stirring, and the solution thus prepared was filtered to obtain a sterilized 2-liter container, which was sealed and sterilized, ≪ / RTI >
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만 수요계층이나, 수요국가, 사용 용도 등 지역적, 민족적 기호도에 따라서 그 배합비율을 임의로 변형 실시하여도 무방하다. 본 발명이 속한 기술 분야에서 통상의 지식을 가진 자라면 상기 내용을 바탕으로 본 발명의 범주 내에서 다양한 응용 및 변형을 행하는 것이 가능할 것이다.Although the composition ratio is mixed with a component suitable for a favorite beverage in a preferred embodiment, the compounding ratio may be arbitrarily modified according to regional and ethnic preferences such as demand hierarchy, demand country, and use purpose. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적 기술은 단지 바람직한 실시태양일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.While the present invention has been particularly shown and described with reference to specific embodiments thereof, those skilled in the art will readily appreciate that many modifications are possible in the exemplary embodiments without materially departing from the novel teachings and advantages of this invention. something to do. Accordingly, the actual scope of the present invention will be defined by the appended claims and their equivalents.
Claims (15)
보리를 열처리 또는 압출 후 건조시키는 단계; 및
열처리 또는 압출 후 건조된 보리에 효모를 가하여 발효시키는 단계를 포함하는,
글루코사민이 증가된 보리의 제조방법.As a method of increasing the glucosamine contained in barley,
Drying the barley after heat treatment or extrusion; And
After the heat treatment or extrusion comprising the step of fermenting by adding yeast to the dried barley,
Method for preparing barley with increased glucosamine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110145876A KR101343944B1 (en) | 2011-12-29 | 2011-12-29 | Method for increasing funtional polysaccharides of barlry |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110145876A KR101343944B1 (en) | 2011-12-29 | 2011-12-29 | Method for increasing funtional polysaccharides of barlry |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130077264A KR20130077264A (en) | 2013-07-09 |
KR101343944B1 true KR101343944B1 (en) | 2013-12-24 |
Family
ID=48990552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110145876A KR101343944B1 (en) | 2011-12-29 | 2011-12-29 | Method for increasing funtional polysaccharides of barlry |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101343944B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160044607A (en) * | 2014-10-02 | 2016-04-26 | 샘표식품 주식회사 | Functional food composition comprising complex ferment consisting of soybean and barley |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100379582B1 (en) * | 2000-03-14 | 2003-04-08 | 황재관 | Physiologically acitive materials from cereals and process for preparation thereof |
KR100952355B1 (en) * | 2008-02-14 | 2010-04-09 | 주식회사 밀투밸런스 | Method for producing fermentation product using natural products and food or medicine comprising fermentation product produced by the method |
-
2011
- 2011-12-29 KR KR1020110145876A patent/KR101343944B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100379582B1 (en) * | 2000-03-14 | 2003-04-08 | 황재관 | Physiologically acitive materials from cereals and process for preparation thereof |
KR100952355B1 (en) * | 2008-02-14 | 2010-04-09 | 주식회사 밀투밸런스 | Method for producing fermentation product using natural products and food or medicine comprising fermentation product produced by the method |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160044607A (en) * | 2014-10-02 | 2016-04-26 | 샘표식품 주식회사 | Functional food composition comprising complex ferment consisting of soybean and barley |
KR101710142B1 (en) * | 2014-10-02 | 2017-02-27 | 샘표 주식회사 | Functional food composition comprising complex ferment consisting of soybean and barley |
Also Published As
Publication number | Publication date |
---|---|
KR20130077264A (en) | 2013-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | In vitro saliva-gastrointestinal digestion and fecal fermentation of Oudemansiella radicata polysaccharides reveal its digestion profile and effect on the modulation of the gut microbiota | |
Su et al. | Effects of different extraction temperatures on the physicochemical properties of bioactive polysaccharides from Grifola frondosa | |
Ye et al. | Structural characterisation and anti-ageing activity of extracellular polysaccharide from a strain of Lachnum sp. | |
CN108118003B (en) | Black yeast, culture medium and method for producing beta-glucan, and black yeast culture and composition containing beta-glucan | |
CN102746963B (en) | High content beta -beer with yeast and preparation method of beer | |
Huang et al. | Dynamic variation in biochemical properties and prebiotic activities of polysaccharides from longan pulp during fermentation process | |
KR20200020804A (en) | Bioactive Oligosaccharide Preparation | |
Wang et al. | Quorum sensing molecule-farnesol increased the production and biological activities of extracellular polysaccharide from Trametes versicolor | |
Tang et al. | Extraction, isolation, structural characterization and prebiotic activity of cell wall polysaccharide from Kluyveromyces marxianus | |
KR20140138490A (en) | Fermented Sparassis crispa and method for preparing the same | |
Sun et al. | Efficient extraction, physiochemical, rheological properties, and antioxidant activities of polysaccharides from Armeniaca vulgaris Lam | |
KR101690779B1 (en) | A method for manufacturing fermented composition comprising red gingseng and rubus coreanus and the fermented composition by the method | |
Yiasmin et al. | Fermentability of Maitake polysaccharides processed by various hydrothermal conditions and fermented with probiotic (Lactobacillus) | |
KR101114495B1 (en) | A functional deer antlers Product produced by two-step process and method for preparing thereof | |
Yang et al. | Structural elucidation of a highly branched α-D-glucan from Huangjiu and its hepatoprotective activity via gut microbiome regulation and intestinal barrier repairment | |
KR101343944B1 (en) | Method for increasing funtional polysaccharides of barlry | |
KR20110122048A (en) | Exopolysaccharides with antioxidant and antiaging activity produced by bacillus sp. strains isolated from kimchi, a fermented korean food and the method for manufacturing the same | |
TW201825668A (en) | Culturing medium and method for producing [beta]-glucan, a culture of Aureobasidium pullulans and a composition comprising the same | |
US10787693B2 (en) | Single-chain beta-glucan composition, method for producing same, and liquid composition | |
JP2006076927A (en) | Fermented material obtained from mango | |
CN107997081A (en) | The processing method that a kind of xylitol preserved fruit freezes | |
CN114027510A (en) | Chlorella pyrenoidosa polysaccharide mixture, preparation method thereof and application of chlorella pyrenoidosa polysaccharide mixture as novel prebiotics | |
KR101629656B1 (en) | Water soluble polysaccharide having immunological enhancement effect and composition comprising the same | |
KR101941646B1 (en) | Aronia tablet comprising fermented aronia and dietary fiber | |
Tan et al. | Physicochemical properties and biological activities of litchi glycans with different molecular weights |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20161102 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20171208 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180928 Year of fee payment: 6 |